Search Query :
5F4N
Multi-parameter lead optimization to give an oral chk1 inhibitor clinical candidate: (r)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (cct245737) Deposition Author(s): Aherne, G.W. , Box, G. , Boxall, K.J. , Brown, N. , Cheung, K.J. , Collins, I. , De Haven Brandon, A.K. , Eccles, S.A. , Eve, P.D. , Garrett, M.D. , Hayes, A. , Henley, A.T. , Jamin, Y. , Lainchbury, M. , Leonard, P. , Matthews, T.P. , Mchardy, T. , Osborne, J.D. , Proisy, N. , Raynaud, F.I. , Reader, J.C. , Robinson, S.P. , Valenti, M.R. , Van Montfort, R. , Walton, M.I. , Westwood, I.M.
Date: 2015-12-03 Method: X-RAY DIFFRACTION Resolution: 1.91 Å Organism(s): N.A. Sequences Data: 5F4N_A